• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

鉴定与 COVID-19 严重程度相关的常规血液和凝血测试中的参数。

Identification of parameters in routine blood and coagulation tests related to the severity of COVID-19.

机构信息

Department of Hepatobiliary Medicine, Shanghai Public Health Clinical Center, Fudan University, Shanghai 201508, China.

Department of Integrative Medicine, Shanghai Public Health Clinical Center, Fudan University, Shanghai 201508, China.

出版信息

Int J Med Sci. 2021 Jan 14;18(5):1207-1215. doi: 10.7150/ijms.47494. eCollection 2021.

DOI:10.7150/ijms.47494
PMID:33526982
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7847620/
Abstract

This study aimed to identify the predictive value of simple markers in routine blood and coagulation tests for the severity of coronavirus disease 2019 (COVID-19). A total of 311 consecutive COVID-19 patients, including 281 patients with mild/moderate COVID-19 and 30 patients with severe/life-threatening COVID-19, were retrospectively enrolled. Logistic modeling and ROC curve analyses were used to assess the indexes for identifying disease severity. Lymphocyte and eosinophil counts of COVID-19 patients in the severe/life-threatening group were significantly lower than those of patients in the mild/moderate group (P < 0.001). Coagulation parameters, high-sensitivity C-reactive protein (hsCRP) levels and procalcitonin levels were higher in the severe/life-threatening group compared with the mild/moderate group (all P < 0.05). Univariate and multivariate logistic models revealed that hsCRP and fibrinogen degradation products (FDPs) were predictors of severe COVID-19 (OR = 1.072, P = 0.036; and OR = 1.831, P = 0.036, respectively). The AUROCs of hsCRP and FDP for predicting severe/life-threatening COVID-19 were 0.850 and 0.766, respectively. The optimal cutoffs of hsCRP and FDP for the severe/life-threatening type of COVID-19 were 22.41 mg/L and 0.95 µg/ml, respectively. Serum CRP and FDP levels are positively related to the severity of COVID-19. This finding indicates that CRP and FDP levels may potentially be used as early predictors for severe illness and help physicians triage numerous patients in a short time.

摘要

本研究旨在确定常规血液和凝血检测中的简单标志物对 2019 年冠状病毒病(COVID-19)严重程度的预测价值。共回顾性纳入 311 例连续 COVID-19 患者,其中 281 例为轻症/中度 COVID-19 患者,30 例为重症/危及生命 COVID-19 患者。采用逻辑建模和 ROC 曲线分析评估识别疾病严重程度的指标。重症/危及生命组 COVID-19 患者的淋巴细胞和嗜酸性粒细胞计数明显低于轻症/中度组(P<0.001)。重症/危及生命组的凝血参数、高敏 C 反应蛋白(hsCRP)水平和降钙素原水平均高于轻症/中度组(均 P<0.05)。单因素和多因素逻辑模型显示,hsCRP 和纤维蛋白原降解产物(FDP)是重症 COVID-19 的预测指标(OR=1.072,P=0.036;OR=1.831,P=0.036)。hsCRP 和 FDP 预测重症/危及生命 COVID-19 的 AUROC 分别为 0.850 和 0.766。hsCRP 和 FDP 预测重症/危及生命 COVID-19 的最佳截断值分别为 22.41mg/L 和 0.95μg/ml。血清 CRP 和 FDP 水平与 COVID-19 的严重程度呈正相关。这一发现表明 CRP 和 FDP 水平可能作为重症的早期预测指标,有助于医生在短时间内对大量患者进行分诊。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4aa0/7847620/53b6aed90bac/ijmsv18p1207g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4aa0/7847620/14efb918a5fb/ijmsv18p1207g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4aa0/7847620/53b6aed90bac/ijmsv18p1207g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4aa0/7847620/14efb918a5fb/ijmsv18p1207g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4aa0/7847620/53b6aed90bac/ijmsv18p1207g002.jpg

相似文献

1
Identification of parameters in routine blood and coagulation tests related to the severity of COVID-19.鉴定与 COVID-19 严重程度相关的常规血液和凝血测试中的参数。
Int J Med Sci. 2021 Jan 14;18(5):1207-1215. doi: 10.7150/ijms.47494. eCollection 2021.
2
The value of clinical parameters in predicting the severity of COVID-19.临床参数在预测 COVID-19 严重程度中的价值。
J Med Virol. 2020 Oct;92(10):2188-2192. doi: 10.1002/jmv.26031. Epub 2020 Jun 2.
3
Prediction of severe illness due to COVID-19 based on an analysis of initial Fibrinogen to Albumin Ratio and Platelet count.基于初始纤维蛋白原与白蛋白比值和血小板计数分析预测 COVID-19 重症。
Platelets. 2020 Jul 3;31(5):674-679. doi: 10.1080/09537104.2020.1760230. Epub 2020 May 5.
4
Evaluation of hematological, coagulation and inflammatory biomarker's role in predicting the severity of disease in patients with COVID-19, admitted in designated COVID-19 hospital of central India.评估血液学、凝血和炎症生物标志物在预测印度中部指定 COVID-19 医院收治的 COVID-19 患者疾病严重程度中的作用。
Indian J Pathol Microbiol. 2021 Oct-Dec;64(4):735-740. doi: 10.4103/IJPM.IJPM_1350_20.
5
Prominent coagulation disorder is closely related to inflammatory response and could be as a prognostic indicator for ICU patients with COVID-19.显著的凝血功能障碍与炎症反应密切相关,可能成为 COVID-19 重症监护病房患者的预后指标。
J Thromb Thrombolysis. 2020 Nov;50(4):825-832. doi: 10.1007/s11239-020-02174-9.
6
A Comprehensive Appraisal of Laboratory Biochemistry Tests as Major Predictors of COVID-19 Severity.实验室生物化学检测对 COVID-19 严重程度的主要预测因素的综合评估。
Arch Pathol Lab Med. 2020 Dec 1;144(12):1457-1464. doi: 10.5858/arpa.2020-0389-SA.
7
The clinical implication of dynamic neutrophil to lymphocyte ratio and D-dimer in COVID-19: A retrospective study in Suzhou China.新冠肺炎患者中性粒细胞与淋巴细胞比值和 D-二聚体的临床意义:中国苏州的一项回顾性研究。
Thromb Res. 2020 Aug;192:3-8. doi: 10.1016/j.thromres.2020.05.006. Epub 2020 May 6.
8
Beclin-1, an autophagy-related protein, is associated with the disease severity of COVID-19.Beclin-1,一种自噬相关蛋白,与 COVID-19 的疾病严重程度相关。
Life Sci. 2021 Aug 1;278:119596. doi: 10.1016/j.lfs.2021.119596. Epub 2021 May 10.
9
Usefulness of biological markers in the early prediction of corona virus disease-2019 severity.生物标志物在预测 2019 年冠状病毒病严重程度中的作用。
Scand J Clin Lab Invest. 2020 Dec;80(8):611-618. doi: 10.1080/00365513.2020.1821396. Epub 2020 Sep 18.
10
Contribution value of coagulation abnormalities in COVID-19 prognosis: a bright perspective on the laboratory pattern of patients with coronavirus disease 2019.凝血异常对 COVID-19 预后的影响:对 2019 年冠状病毒病患者实验室模式的新认识。
Eur Rev Med Pharmacol Sci. 2021 Jan;25(1):518-522. doi: 10.26355/eurrev_202101_24423.

引用本文的文献

1
Associated Biochemical and Hematological Markers in COVID-19 Severity Prediction.新冠病毒疾病严重程度预测中的相关生化和血液学标志物
Adv Med. 2023 Oct 19;2023:6216528. doi: 10.1155/2023/6216528. eCollection 2023.
2
The Immune, Inflammatory and Hematological Response in COVID-19 Patients, According to the Severity of the Disease.新型冠状病毒肺炎患者的免疫、炎症及血液学反应与疾病严重程度的关系
Microorganisms. 2023 Jan 27;11(2):319. doi: 10.3390/microorganisms11020319.
3
Risk of Death in Comorbidity Subgroups of Hospitalized COVID-19 Patients Inferred by Routine Laboratory Markers of Systemic Inflammation on Admission: A Retrospective Study.

本文引用的文献

1
Characteristics of coagulation alteration in patients with COVID-19.新型冠状病毒肺炎患者凝血功能改变的特点。
Ann Hematol. 2021 Jan;100(1):45-52. doi: 10.1007/s00277-020-04305-x. Epub 2020 Oct 20.
2
Clinical and laboratory features of COVID-19: Predictors of severe prognosis.新型冠状病毒肺炎的临床和实验室特征:严重预后的预测因素。
Int Immunopharmacol. 2020 Nov;88:106950. doi: 10.1016/j.intimp.2020.106950. Epub 2020 Sep 9.
3
Early coagulation tests predict risk stratification and prognosis of COVID-19.早期凝血检测可预测新型冠状病毒肺炎的风险分层及预后。
入院时常规全身炎症标志物推断的住院 COVID-19 患者合并症亚组的死亡风险:一项回顾性研究。
Viruses. 2022 May 31;14(6):1201. doi: 10.3390/v14061201.
4
Diagnostic Accuracy of Liquid Biomarkers in Airway Diseases: Toward Point-of-Care Applications.气道疾病中液体生物标志物的诊断准确性:迈向即时护理应用
Front Med (Lausanne). 2022 Jun 6;9:855250. doi: 10.3389/fmed.2022.855250. eCollection 2022.
5
Meta-Analysis and Systematic Review of Coagulation Disbalances in COVID-19: 41 Studies and 17,601 Patients.COVID-19凝血失衡的Meta分析与系统评价:41项研究及17601例患者
Front Cardiovasc Med. 2022 Mar 11;9:794092. doi: 10.3389/fcvm.2022.794092. eCollection 2022.
6
Identification of hematological and inflammatory parameters associated with disease severity in hospitalized patients of COVID-19.新冠病毒肺炎住院患者中与疾病严重程度相关的血液学和炎症参数的识别
J Family Med Prim Care. 2022 Jan;11(1):260-264. doi: 10.4103/jfmpc.jfmpc_941_21. Epub 2022 Jan 31.
7
Emerging Role of Phospholipase-Derived Cleavage Products in Regulating Eosinophil Activity: Focus on Lysophospholipids, Polyunsaturated Fatty Acids and Eicosanoids.磷脂酶衍生裂解产物在调节嗜酸性粒细胞活性中的新作用:重点关注溶血磷脂、多不饱和脂肪酸和类二十烷酸。
Int J Mol Sci. 2021 Apr 21;22(9):4356. doi: 10.3390/ijms22094356.
Aging (Albany NY). 2020 Aug 29;12(16):15918-15937. doi: 10.18632/aging.103581.
4
Prominent coagulation disorder is closely related to inflammatory response and could be as a prognostic indicator for ICU patients with COVID-19.显著的凝血功能障碍与炎症反应密切相关,可能成为 COVID-19 重症监护病房患者的预后指标。
J Thromb Thrombolysis. 2020 Nov;50(4):825-832. doi: 10.1007/s11239-020-02174-9.
5
Diagnostic value of peripheral hematologic markers for coronavirus disease 2019 (COVID-19): A multicenter, cross-sectional study.外周血标志物对 2019 年冠状病毒病(COVID-19)的诊断价值:一项多中心、横断面研究。
J Clin Lab Anal. 2020 Oct;34(10):e23475. doi: 10.1002/jcla.23475. Epub 2020 Jul 17.
6
C-reactive protein, procalcitonin, D-dimer, and ferritin in severe coronavirus disease-2019: a meta-analysis.C 反应蛋白、降钙素原、D-二聚体和铁蛋白在严重 2019 冠状病毒病中的meta 分析。
Ther Adv Respir Dis. 2020 Jan-Dec;14:1753466620937175. doi: 10.1177/1753466620937175.
7
Biomarkers associated with COVID-19 disease progression.与 COVID-19 疾病进展相关的生物标志物。
Crit Rev Clin Lab Sci. 2020 Sep;57(6):389-399. doi: 10.1080/10408363.2020.1770685. Epub 2020 Jun 5.
8
COVID-19 and coagulation: bleeding and thrombotic manifestations of SARS-CoV-2 infection.COVID-19 和凝血:SARS-CoV-2 感染的出血和血栓形成表现。
Blood. 2020 Jul 23;136(4):489-500. doi: 10.1182/blood.2020006520.
9
Elevated levels of IL-6 and CRP predict the need for mechanical ventilation in COVID-19.IL-6 和 CRP 水平升高可预测 COVID-19 患者需要机械通气。
J Allergy Clin Immunol. 2020 Jul;146(1):128-136.e4. doi: 10.1016/j.jaci.2020.05.008. Epub 2020 May 18.
10
Characterisation of COVID-19 Pandemic in Paediatric Age Group: A Systematic Review and Meta-Analysis.儿童期 COVID-19 大流行特征:系统评价和荟萃分析。
J Clin Virol. 2020 Jul;128:104395. doi: 10.1016/j.jcv.2020.104395. Epub 2020 May 8.